Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Tanlimco SG"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Purcell JW; AbbVie Biotherapeutics, Redwood City, California. james.purcell@abbvie.com., Tanlimco SG; AbbVie Biotherapeutics, Redwood City, California., Hickson J; AbbVie Inc., North Chicago, Illinois., Fox M; AbbVie Biotherapeutics, Redwood City, California., Sho M; AbbVie Biotherapeutics, Redwood City, California., Durkin L; Cleveland Clinic, Cleveland, Ohio., Uziel T; AbbVie Inc., North Chicago, Illinois., Powers R; AbbVie Biotherapeutics, Redwood City, California., Foster K; AbbVie Inc., North Chicago, Illinois., McGonigal T; AbbVie Inc., North Chicago, Illinois., Kumar S; AbbVie Biotherapeutics, Redwood City, California., Samayoa J; AbbVie Biotherapeutics, Redwood City, California., Zhang D; AbbVie Biotherapeutics, Redwood City, California., Palma JP; AbbVie Inc., North Chicago, Illinois., Mishra S; AbbVie Inc., North Chicago, Illinois., Hollenbaugh D; AbbVie Biotherapeutics, Redwood City, California., Gish K; AbbVie Biotherapeutics, Redwood City, California., Morgan-Lappe SE; AbbVie Inc., North Chicago, Illinois., Hsi ED; Cleveland Clinic, Cleveland, Ohio., Chao DT; AbbVie Biotherapeutics, Redwood City, California.
Publikováno v:
Cancer research [Cancer Res] 2018 Jul 15; Vol. 78 (14), pp. 4059-4072. Date of Electronic Publication: 2018 May 15.
Autor:
Turan T; Immune-Oncology Discovery, AbbVie, Redwood City, CA, USA., Kannan D; Immune-Oncology Discovery, AbbVie, Redwood City, CA, USA., Patel M; Clinical Pharmacology and Pharmacometrics, Abbvie, Redwood City, CA, USA., Matthew Barnes J; Immune-Oncology Discovery, AbbVie, Redwood City, CA, USA., Tanlimco SG; Immune-Oncology Discovery, AbbVie, Redwood City, CA, USA., Lu R; Immune-Oncology Discovery, AbbVie, Redwood City, CA, USA., Halliwill K; Immune-Oncology Discovery, AbbVie, Redwood City, CA, USA., Kongpachith S; Immune-Oncology Discovery, AbbVie, Redwood City, CA, USA., Kline DE; Immune-Oncology, AbbVie, North Chicago, IL, USA., Hendrickx W; Tumor Biology, Immunology, and Therapy Section, Division of Translational Medicine, Research Branch, Sidra Medical and Research Center, Doha, Qatar., Cesano A; Nanostring Technologies, Inc., Seattle, WA, USA., Butterfield LH; UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA., Kaufman HL; Departments of Surgery and Medicine, Rutgers University, New Jersey, NJ, USA., Hudson TJ; Immune-Oncology Discovery, AbbVie, Redwood City, CA, USA., Bedognetti D; Tumor Biology, Immunology, and Therapy Section, Division of Translational Medicine, Research Branch, Sidra Medical and Research Center, Doha, Qatar., Marincola F; Immune-Oncology Discovery, AbbVie, Redwood City, CA, USA., Samayoa J; Immune-Oncology Discovery, AbbVie, Redwood City, CA, USA. josue.samayoa@abbvie.com.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2018 Jun 05; Vol. 6 (1), pp. 50. Date of Electronic Publication: 2018 Jun 05.
Autor:
Purcell JW; Department of Biologics Technologies, AbbVie Biotherapeutics , Redwood City, CA , USA., Kim HK; Department of Biologics Technologies, AbbVie Biotherapeutics , Redwood City, CA , USA., Tanlimco SG; Department of Biologics Technologies, AbbVie Biotherapeutics , Redwood City, CA , USA., Doan M; Department of Biologics Technologies, AbbVie Biotherapeutics , Redwood City, CA , USA., Fox M; Department of Oncology Biologics, AbbVie Biotherapeutics , Redwood City, CA , USA., Lambert P; Department of Biologics Technologies, AbbVie Biotherapeutics , Redwood City, CA , USA., Chao DT; Department of Biologics Technologies, AbbVie Biotherapeutics , Redwood City, CA , USA., Sho M; Department of Biologics Technologies, AbbVie Biotherapeutics , Redwood City, CA , USA., Wilson KE; Department of Biologics Technologies, AbbVie Biotherapeutics , Redwood City, CA , USA., Starling GC; Department of Oncology Biologics, AbbVie Biotherapeutics , Redwood City, CA , USA., Culp PA; Department of Oncology Biologics, AbbVie Biotherapeutics , Redwood City, CA , USA.
Publikováno v:
Frontiers in immunology [Front Immunol] 2014 Jan 08; Vol. 4, pp. 505. Date of Electronic Publication: 2014 Jan 08 (Print Publication: 2014).